当前位置:首页>公司>新闻专栏>>


GENEWIZ, Inc. and Biomatters Announce Strategic Partnership to Align DNA-Based Services and Analysis Software



South Plainfield, NJ and Auckland, New Zealand - June 1, 2011 - GENEWIZ, Inc., the #1 provider of DNA sequencing services in the United States, and Biomatters, creators of the leading DNA sequence analysis software Geneious Pro, announced a strategic partnership to provide integrated solutions to streamline DNA-based services from ordering to data analysis. 

This partnership signifies a close technical integration between the companies' products and services. GENEWIZ customers will have the ability to download data directly into Geneious Pro for immediate visualization and analysis, which is particularly important for large volume users. Additionally, customers will have the option to submit in silico designed sequences or oligonucleotides for synthesis to GENEWIZ and analysis directly from Geneious Pro. 

GENEWIZ will also provide customers with sequence results in the native Geneious file format as well as in other standard formats. Furthermore, GENEWIZ customers will be able to visualize their data in Geneious, giving them access to professional visualization and analysis tools as well as best-in-class bioinformatics support for downstream analysis. 

"With a common mission to discover innovative scientific solutions, as well as to deliver the highest quality service, I am confident that our partnership with Biomatters will prove advantageous to customers' research," stated Dr. Shifang Zhang, GENEWIZ Vice President of Corporate Development. "The additional analysis tools offered, as well as the integration with Geneious Pro, will enable customers to further centralize sequencing data for easy access, analysis, and management."

"GENEWIZ is the leader in their field, and by working together we are able to dramatically streamline the workflows of a vast number of researchers. With the large volumes of data scientists must manage these days, saving minutes per sample quickly adds up, fostering significant time savings," commented Candace Kinser, Biomatters CEO. 

GENEWIZ and Biomatters will also undertake joint marketing and referral campaigns. The companies have complementary customer bases; GENEWIZ customers require the types of analysis tools available through Geneious Pro, and Biomatters customers require the high-quality, cost-efficient commercial laboratory services offered by GENEWIZ. 

"It’s all about making life easier for biologists, so that they can concentrate on the biology," Kinser added. 

About GENEWIZ, Inc.

GENEWIZ, Inc. is a contract research organization (CRO) specializing in DNA-based services including DNA sequencing, gene synthesis, molecular biology, genomic, and GxP/CLIA regulatory-compliant services. The company leads the industry in U.S. research sequencing and outsourcing partnerships with pharmaceutical, clinical, biotechnology, academic, and government institutions. 

Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held, global enterprise with additional laboratory locations in San Diego, Boston, Washington D.C. Metro, Beijing, China, and Suzhou, China. For more information, please visit www.genewiz.com or call 1-877-436-3949 x3207. 

About Biomatters, Ltd. 

Biomatters is a privately-held New Zealand company, with headquarters in Auckland, New Zealand. It is currently establishing a U.S. office in New Jersey. 

Biomatters creates software that can be used by all researchers in their daily work. Biomatters' technology converts raw data into meaningful, visual information, simplifying research, accelerating biological research and ultimately improving efficiency. 

Biomatters' Geneious Pro desktop software is used in over 2500 research organizations in more than 65 countries and in all of the world’s top 25 universities. 

For more information visit www.geneious.com.